Dr. Lal Path Labs Ltd. (LALPATHLAB) — Capital Reinvestment Ratio

Latest as of September 2025: 0.41x

Dr. Lal Path Labs Ltd. (LALPATHLAB) has a Capital Reinvestment Ratio of 0.41x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs3.24 Billion) in capital expenditures (Rs1.34 Billion). See Dr. Lal Path Labs Ltd. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.41x
Capex / Operating Cash Flow

Operating Cash Flow

Rs3.24 Billion
INR

Capital Expenditures

Rs1.34 Billion
INR

Data as of

Sep 2025
Most recent filing

Dr. Lal Path Labs Ltd. Capital Reinvestment Ratio (2011–2026)

This chart tracks Dr. Lal Path Labs Ltd.'s Capital Reinvestment Ratio across 16 annual periods.

Annual Capital Reinvestment Ratio for Dr. Lal Path Labs Ltd. (2011–2026)

Year-by-year Capital Reinvestment Ratio for Dr. Lal Path Labs Ltd. from 2011 to 2026. For live market cap and broader valuation context, see LALPATHLAB market cap.

Year Reinvestment Ratio Operating CF (INR) Capital Expenditures YoY Change
2026 0.24x Rs7.02 Billion Rs1.67 Billion ▲ +205.4%
2025 0.08x Rs5.69 Billion Rs443.00 Million ▼ -18.5%
2024 0.10x Rs5.35 Billion Rs511.67 Million ▼ -2.3%
2023 0.10x Rs4.56 Billion Rs446.00 Million ▼ -90.8%
2022 1.07x Rs4.47 Billion Rs4.76 Billion ▲ +612.2%
2021 0.15x Rs3.98 Billion Rs595.90 Million ▼ -46.6%
2020 0.28x Rs2.84 Billion Rs796.17 Million ▲ +45.8%
2019 0.19x Rs2.19 Billion Rs420.38 Million ▼ -47.7%
2018 0.37x Rs1.97 Billion Rs724.69 Million ▲ +22.3%
2017 0.30x Rs1.72 Billion Rs515.91 Million ▲ +0.0%
2016 0.30x Rs1.47 Billion Rs441.27 Million ▼ -16.7%
2015 0.36x Rs978.50 Million Rs352.93 Million ▲ +7.8%
2014 0.33x Rs979.58 Million Rs327.63 Million ▲ +50.2%
2013 0.22x Rs881.31 Million Rs196.20 Million ▼ -28.2%
2012 0.31x Rs681.28 Million Rs211.26 Million ▼ -46.2%
2011 0.58x Rs417.87 Million Rs240.74 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow